The Alnylam Pharmaceuticals, Inc. (ALNY) ROIC is (19.0%), compared to the industry median of ((122.4%)) and the 5-year historical average of (72.8%).
The Alnylam Pharmaceuticals, Inc. (ALNY) ROIC minus WACC is (25.8%), compared to the industry median of ((129.8%)) and the 5-year historical average of (78.4%).
The Alnylam Pharmaceuticals, Inc. (ALNY) ROE is (2,269.0%), compared to the industry median of ((52.2%)) and the 5-year historical average of (163.4%).
The Alnylam Pharmaceuticals, Inc. (ALNY) ROCE is (6.7%), compared to the industry median of ((51.2%)) and the 5-year historical average of (26.1%).